Streetbeat News

Products Services

DNTH

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) announced two poster presentations for its drug candidate DNTH103 at the 10th Congress of the European Academy of Neurology, scheduled for June 29-July 2, 2024, in Helsinki.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 3:32 pm

CMND

Clearmind Medicine shares are trading higher following the announcement of a patent approval in Hong Kong for its MEAI-based binge behavior regulator program.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 3:32 pm

JNJ

Johnson & Johnson announced positive results from the nipocalimab Phase 3 Vivacity-MG3 study, showing significant improvement in patients with generalized myasthenia gravis. The study demonstrated superiority in activities of daily living over placebo when added to standard care over 24 weeks. These results will be presented at the European Academy of Neurology 2024 Congress and included in regulatory submissions later this year.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 3:31 pm

TEVA

Teva Pharmaceuticals presented the 4th interim analysis of the PEARL migraine prevention study at the EAN Congress. A new sub-analysis highlights the potential negative impact of treatment pauses on patient outcomes, suggesting a rise in migraine attacks and diminished treatment effectiveness upon reinitiation.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 3:31 pm

BTCUSD

The Core Foundation is launching the world's first yield-bearing CORE ETP on the Spotlight Stock Exchange, facilitated by Valour, a subsidiary of DeFi Technologies. This ETP will provide exposure to Core blockchain's native token and follows the successful release of Valour's Bitcoin Staking ETP.

Portfolio Pulse from Murtuza Merchant

June 28, 2024 | 3:28 pm

GOOGL

META

SNAP

TikTok has applied for the 'Genie' trademark in the U.S. for an AI chatbot, indicating its move into the AI space. This development could impact competitors like Meta, Google, and Snap, who are also investing in AI technologies.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 3:28 pm

META

Meta CEO Mark Zuckerberg announced that the company is 'almost ready' to reveal a prototype of its advanced augmented reality (AR) glasses, which have left early testers 'giddy.' The prototype, distinct from headsets like the Quest, will be showcased at Meta's annual Connect conference in the fall. Although not yet ready for sale, the demonstration aims to generate excitement around Meta's AR technology investments.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 3:26 pm

BIDU

Baidu Inc (NASDAQ:BIDU) has hit a 52-week low, reflecting a 38% decline over the past year and a 25% drop year-to-date. The company reported a 7% decline in first-quarter revenue due to China's slowing economy and competition from local rivals. Despite the bearish trend, Baidu is making strategic moves in the AI market, offering free AI model fine-tuning and expert guidance to attract developers.

Portfolio Pulse from Surbhi Jain

June 28, 2024 | 3:21 pm

ORCL

High-rolling investors have shown significant interest in Oracle (NYSE:ORCL) options, with a notable split in sentiment: 41% bullish and 50% bearish. This unusual activity, detected by Benzinga's options scanner, includes 12 trades with a total of $605,192 in calls and puts. The price window for these options ranges from $115.0 to $165.0. Oracle's stock is currently trading at $142.38, up by 1.57%, but RSI readings suggest it may be overbought.

Portfolio Pulse from Benzinga Insights

June 28, 2024 | 3:16 pm

AGEN

Agenus announced that its extended BOT/BAL therapy has shown significant tumor reductions in colon cancer. The results were presented at the 2024 ESMO Gastrointestinal Cancers Congress.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 3:10 pm